2014-05-27 Just look, but don’t touch: EMA terms of use for clinical study data are impracticable Data are only allowed to be viewed on screen / Pre-censorship by drug manufacturers The European Medicines Agency (EMA) receives comprehensive clinical study data… Read More ›
EMA
Europe says No to drug data access ” arguing that this would undermine commercial interests and that there was no overriding public interest in disclosure”
Public release date: 10-May-2011 – Request Repost Drug regulators are protecting profits over patients, warn researchers Analysis: Opening up data at the European Medicines Agency Medicines regulators are protecting drug company profits rather than the lives and welfare of patients… Read More ›